ArticleFrontiers in public health2025
Barriers and enablers of HPV vaccination among caregivers of school-age girls in resource-limited regions of Western Sichuan, China: a mixed-methods study.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Urban-rural disparities in HPV vaccination knowledge, willingness, and uptake among women in the Tibet autonomous region: a multi-center cross-sectional study.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The HPV infection rate in Sichuan exceeds the national average. The provincial government has initiated vaccination programs, with a particular focus on impoverished areas such as the Ganzi, Aba, and Liangshan prefectures, where both the HPV disease burden is elevated and vaccination uptake remains suboptimal. This study aimed to investigate HPV vaccination among adolescent girls in these prefectures, evaluate caregivers' knowledge and attitudes, identify factors influencing their willingness to vaccinate their daughters, and examine existing policies to provide evidence-based recommendations for improving vaccination strategies. Methods: A cross-sectional study was conducted in Ganzi, Aba, and Liangshan prefectures from September 2023 to May 2024, integrating both quantitative and qualitative methods. At least 2,034 caregivers and 75 participants should be recruited for the quantitative and qualitative studies, respectively. Questionnaires were used to assess caregivers' willingness to vaccinate girls under the age of 15. Quantitative analyses included Chi-square tests, Mann-Whitney U tests, and logistic regression analyses. Additionally, focus group discussions and face-to-face interviews with vaccination personnel and caregivers explored vaccination coverage and barriers, with qualitative data analyzed via thematic framework analysis. Results: A total of 2,397 caregivers completed valid questionnaires, with 59.28% having heard of HPV and 69.63% being aware of the HPV vaccine. Although 92.12% expressed willingness to vaccinate their girls against HPV, the actual vaccination rate was only 6.59%. Reluctance to vaccinate was primarily due to a lack of knowledge about the vaccine (30.69%), concern about potential side effects (28.04%), and uncertainty about the vaccine's effectiveness (18.5%). Regression analysis showed that caregivers who were mothers, willing to pay for HPV vaccination, personally willing to receive the HPV vaccine, and had never refused a vaccine were more likely to vaccinate girls against HPV (all Conclusion: Caregivers hold positive attitudes toward HPV vaccination, but the coverage rate among girls remains low in Ganzi, Aba, and Liangshan prefectures. Ensuring vaccine supply, reducing costs, improving caregivers' knowledge, and increasing vaccination accessibility could significantly enhance vaccination rates in resource-limited regions of western China.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.